These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27816992)

  • 1. Impaired heart rate variability in cervical dystonia is associated to depression.
    Hentschel F; Dressler D; Abele M; Paus S
    J Neural Transm (Vienna); 2017 Feb; 124(2):245-251. PubMed ID: 27816992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.
    Müller J; Kemmler G; Wissel J; Schneider A; Voller B; Grossmann J; Diez J; Homann N; Wenning GK; Schnider P; Poewe W;
    J Neurol; 2002 Jul; 249(7):842-6. PubMed ID: 12140667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of disability in cervical dystonia.
    van den Dool J; Tijssen MA; Koelman JH; Engelbert RH; Visser B
    Parkinsonism Relat Disord; 2016 Nov; 32():48-53. PubMed ID: 27553512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in long-term botulinum toxin treatment of cervical dystonia: Results of a cross sectional study.
    Moll M; Rosenthal D; Hefter H
    Parkinsonism Relat Disord; 2018 Dec; 57():63-67. PubMed ID: 30150129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond a motor disorder: a prospective evaluation of sleep quality in cervical dystonia.
    Eichenseer SR; Stebbins GT; Comella CL
    Parkinsonism Relat Disord; 2014 Apr; 20(4):405-8. PubMed ID: 24486141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional activity of the sensorimotor cortex and cerebellum relates to cervical dystonia symptoms.
    Burciu RG; Hess CW; Coombes SA; Ofori E; Shukla P; Chung JW; McFarland NR; Wagle Shukla A; Okun MS; Vaillancourt DE
    Hum Brain Mapp; 2017 Sep; 38(9):4563-4573. PubMed ID: 28594097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic dysfunction: a link between depression and cardiovascular mortality? The FINE Study.
    Kamphuis MH; Geerlings MI; Dekker JM; Giampaoli S; Nissinen A; Grobbee DE; Kromhout D
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):796-802. PubMed ID: 18043302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in individuals with cervical dystonia before botulinum toxin injection in a Brazilian tertiary care hospital.
    Queiroz MR; Chien HF; Barbosa ER
    Arq Neuropsiquiatr; 2011 Dec; 69(6):900-4. PubMed ID: 22297876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
    Samotus O; Lee J; Jog M
    J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a single botulinum toxin treatment on somatosensory processing in idiopathic isolated cervical dystonia: an observational study.
    De Pauw J; Cras P; Truijen S; Mercelis R; Michiels S; Saeys W; Vereeck L; Hallemans A; De Hertogh W
    J Neurol; 2018 Nov; 265(11):2672-2683. PubMed ID: 30196326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasticity of static graviceptive function in patients with cervical dystonia.
    Platho-Elwischger K; Kranz G; Sycha T; Dunkler D; Rommer P; Mueller C; Auff E; Wiest G
    J Neurol Sci; 2017 Feb; 373():230-235. PubMed ID: 28131194
    [No Abstract]   [Full Text] [Related]  

  • 13. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
    Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
    Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The physical, social and emotional aspects are the most affected in the quality of life of the patients with cervical dystonia.
    Werle RW; Takeda SY; Zonta MB; Guimarães AT; Teive HA
    Arq Neuropsiquiatr; 2014 Jun; 72(6):405-10. PubMed ID: 24964104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia.
    Dressler D; Kupsch A; Seitzinger A; Paus S
    Eur J Neurol; 2014 Mar; 21(3):459-62. PubMed ID: 24433495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic side effects of botulinum toxin type B therapy.
    Dressler D; Benecke R
    Adv Neurol; 2004; 94():315-20. PubMed ID: 14509689
    [No Abstract]   [Full Text] [Related]  

  • 18. Depression in patients with acute myocardial infarction: influence on autonomic nervous system and prognostic role. Results of a five-year follow-up study.
    Drago S; Bergerone S; Anselmino M; Varalda PG; Cascio B; Palumbo L; Angelini G; Trevi PG
    Int J Cardiol; 2007 Jan; 115(1):46-51. PubMed ID: 16797746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.
    Misra VP; Colosimo C; Charles D; Chung TM; Maisonobe P; Om S;
    J Neurol; 2018 Feb; 265(2):402-409. PubMed ID: 29270685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical dystonia patients display subclinical gait changes.
    Esposito M; Dubbioso R; Peluso S; Picone A; Corrado B; Servodio Iammarone C; Allocca R; Manganelli F; Santoro L; Fasano A
    Parkinsonism Relat Disord; 2017 Oct; 43():97-100. PubMed ID: 28712731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.